Article
RANKOR: Direct Drug Prioritization from Bulk and Single-Cell Transcriptomic Signatures
2026-05-21
Abstract excerpt
<h4>Background</h4> Prioritizing therapeutics from transcriptomic data remains a key challenge in precision medicine. Signature reversal approaches, most commonly implemented through Gene Set Enrichment Analysis (GSEA), have been widely used to match disease signatures to candidate drugs. However, enrichment-based methods can be sensitive to noise and are restricted to previously profiled compounds <h4>Methods</h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ca5eb2c-cf50-509c-81d0-95201f2d1480
- DOI
- 10.64898/2026.05.20.726471
